Biological activity evaluation of novel monoamine oxidase inhibitory compounds targeting Parkinson disease

Conceptualization, AC Karaburun, N Gundogdu-Karaburun, AE Evren, and S Dawbaa; methodology, AC Karaburun, BN Sağlik, S Dawbaa and AE Evren; software, AE Evren, BN Sağlik and S Dawbaa; formal analysis, S Dawbaa and AE Evren; investigation, S Dawbaa and AE Evren; resources, AC Karaburun, NG Gundogdu-Karaburun, AE Evren and S Dawbaa; writing—original draft preparation, AC Karaburun, S Dawbaa and AE Evren; writing—review and editing N Gundogdu-Karaburun; visualization, AE Evren and Dawbaa; supervision, AC Karaburun and N Gundogdu-Karaburun; project administration, AC Karaburun; funding acquisition, AC Karaburun. All authors have read and agreed to the published version of the manuscript.

留言 (0)

沒有登入
gif